Delivery Order SPE2DB22D9367-SPE2DB25FSZ33
- Not listed
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $4,166.24 to DMS Pharmaceutical Group Inc. for 52 mg Mirena systems, with an ultimate completion date of September 15, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA under the SPE2DB program, a...
- The Defense Logistics Agency awarded a $26,038.50 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mirena 52 mg contraceptive systems. The delivery order, issued on July 21, 2025, with an ultimate completion date of August 11, 2025, carries no set-aside designation. This award is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc. a delivery order valued at $5,207.70 for Mirena 52 mg systems, effective July 21, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order represents a discrete procurement under DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with DLA, valued at approximately $500 million through November 2026. The award carries no set-aside designation, allowing the woman-owned small...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $3,124.68 to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of September 4, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order will be performed at the company's location in Park Ridge, Illinois. This delivery order is issued under DMS...
- The Defense Logistics Agency awarded a delivery order valued at $1,041.56 to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order was issued without a set-aside designation and represents a supply of contraceptive medical devices to support Department of Defense healthcare requirements. The work will be performed at the vendor's location in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a...
- The Defense Logistics Agency awarded a $6,249.24 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for Mirena 52 mg systems. The award was issued on July 28, 2025, with an ultimate completion date of August 18, 2025. No set-aside designation was used for this procurement. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $11,840.00 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Mirena 52 mg Systems, a type of intrauterine contraceptive device, with a period of performance through January 10, 2025. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a wide range of branded and generic...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,645.39 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the provision of Mirena 52 mg systems. The contract, issued on July 25, 2025, with an ultimate completion date of August 15, 2025, operates under a firm fixed-price structure with no set-aside designation applied. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite...
- The U.S. Defense Logistics Agency (DLA) awarded a $8,880.00 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the provision of Mirena 52 mg intrauterine systems. This delivery order is placed against DMS Pharmaceutical Group's existing $4,999,999 indefinite delivery contract with DLA for pharmaceutical products, which supports the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group is a...
- The Defense Logistics Agency awarded a delivery order valued at $5,207.70 to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of August 8, 2025. This firm fixed-price delivery order was issued without a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform the work at its primary location. The company has been registered in the System for Award...
- SPE2DB22D9367Indefinite Delivery Contract
- SPE2DB22D9367-SPE2DB25FSZ33Delivery Order
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $3,124.68 to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of September 15, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order falls under the company's larger Indefinite Delivery Contract with DLA valued at approximately $500 million through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies for military health facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively in government procurement markets. The company specializes in distributing branded and generic prescription drugs, biologics, vaccines, and medical consumables to Department of Defense healthcare facilities. This particular delivery order for Mirena contraceptive devices represents one of numerous pharmaceutical product deliveries the company fulfills under its SPE2DB program contract with DLA, which encompasses medications spanning oncology treatments, auto-injectors, specialty pharmaceuticals, and various other medical supplies supporting military health operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 8/22/25 |